Stockscreener 앱 받기
5.24
6.88%
0.36
Immix Biopharma Inc 주식(IMMX)의 최신 뉴스
Is Immix Biopharma Inc (IMMX) positioned for future growth? - Setenews
Immix Biopharma, Inc.'s (NASDAQ:IMMX) market cap rose US$18m last week; retail investors who hold 56% profited and so did insiders - simplywall.st
Immix Biopharma (NASDAQ:IMMX) Trading 4.5% Higher – What’s Next? - Defense World
What analysts say about Immix Biopharma Inc stockSector Rotation Strategies & Our Experts Decode Market Noise for You - earlytimes.in
Is Immix Biopharma Inc a good long term investmentMarket Depth Overview & Watch and Learn From Live Trades - earlytimes.in
Will Immix Biopharma Inc. stock benefit from automationJuly 2025 Catalysts & Accurate Intraday Trade Tips - BỘ NỘI VỤ
Immix Biopharma appoints Michael Grabow as chief commercial officer to drive NXC-201 launch - MSN
A significant driver of top-line growth: Immix Biopharma Inc (IMMX) - Setenews
Immix Biopharma Updates Accounting Firm Consents - MSN
Immix Biopharma files updated auditor consents for SEC registration statement - Investing.com Nigeria
Immix Biopharma Inc. (IMMX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Immix Biopharma Updates Auditor Consents for Registration Statement - TradingView
[8-K] Immix Biopharma, Inc. Reports Material Event | IMMX SEC FilingForm 8-K - Stock Titan
Is Variman Global Enterprises Limited Worth Holding Through Market ReversalDividend Cut Warnings & Low Cost Capital Trading - earlytimes.in
We Think Immix Biopharma (NASDAQ:IMMX) Needs To Drive Business Growth Carefully - Yahoo Finance
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Will Immix Biopharma Inc. stock rally after Fed decisionsQuarterly Risk Review & Real-Time Buy Zone Alerts - newser.com
Working capital per share of Immix Biopharma, Inc. – NASDAQ:IMMX - TradingView
Can trapped investors hope for a rebound in Immix Biopharma Inc.July 2025 Recap & High Conviction Buy Zone Picks - newser.com
How rising interest rates impact Immix Biopharma Inc. stockPortfolio Value Report & Weekly Hot Stock Watchlists - newser.com
Immix Biopharma’s NXC-201 CAR-T Study: A Potential Game-Changer for AL Amyloidosis - MSN
Will Immix Biopharma Inc. see short term momentum2025 Winners & Losers & Verified Swing Trading Watchlists - newser.com
How Immix Biopharma Inc. stock valuations compare to rivalsJuly 2025 Trends & Safe Capital Growth Tips - newser.com
ETFs Investing in Immix Biopharma, Inc. Stocks - TradingView
What the charts say about Immix Biopharma Inc. todayMarket Rally & AI Enhanced Execution Alerts - newser.com
How Immix Biopharma Inc. stock reacts to bond yieldsPortfolio Performance Summary & Short-Term High Return Ideas - newser.com
Immix Biopharma Inc. stock trendline breakdownEarnings Trend Report & Weekly High Conviction Ideas - newser.com
Immix Biopharma Inc Stock Analysis and ForecastEarnings Beat Highlights & Free Expert Guidance For Growth - earlytimes.in
Why Immix Biopharma Inc. stock appeals to dividend seekers2025 Top Gainers & Daily Profit Maximizing Tips - newser.com
Will Immix Biopharma Inc. stock sustain high P E ratiosEarnings Trend Report & Consistent Income Trade Recommendations - Fundação Cultural do Pará
A History of Outperforming Analyst Forecasts and Beating the Odds: Immix Biopharma Inc (IMMX) - Setenews
Best Biotech Stocks Right Now • Updated Daily - Benzinga
Risk adjusted return profile for Immix Biopharma Inc. analyzedJuly 2025 Price Swings & Capital Efficient Trade Techniques - newser.com
Immix Biopharma appoints Grabow as Chief Commercial Officer - MSN
EBIT per share of Immix Biopharma, Inc. – NASDAQ:IMMX - TradingView
Immix Biopharma appoints commercial leader to head NXC-201 launch By Investing.com - Investing.com Australia
0.82%
1.03%
자본화:
|
볼륨(24시간):